PHARMACEUTICAL COMBINATION COMPRISING A CLASS III RECEPTOR TYROSINE KINASE INHIBITOR AND THE ALKYLATING HISTONE DEACETYLASE INHIBITOR FUSION MOLECULE EDO S101 TOGETHER WITH ITS USE IN THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

发明人:

MEHRLING THOMAS JORG

申请号：

IN201617041053

公开号：

IN201617041053A

申请日:

2016.12.01

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

The present invention is directed to a combination comprising a class III receptor tyrosine kinase inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination to the combination composition or kit for use in the treatment of cancer and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination composition or kit.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/